UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
WASHINGTON,
DC 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO
SECTION 13 OR 15(D) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of report
(Date of earliest event reported): February 8, 2016 (February 8, 2016)
Phibro Animal
Health Corporation
(EXACT NAME OF REGISTRANT AS SPECIFIED
IN CHARTER)
|
Delaware |
|
01-36410 |
|
13-1840497 |
(State
or other jurisdiction of
incorporation) |
|
(Commission
File Number) |
|
(IRS
Employer Identification No.) |
Glenpointe Centre East, 3rd Floor
300 Frank W. Burr Boulevard, Suite 21
Teaneck, New Jersey 07666-6712
(Address of
Principal Executive Offices, including Zip Code)
(201) 329-7300
(Registrant’s
telephone number, including area code)
Not Applicable
(Former name
or former address, if changed since last report)
Check the appropriate box below if this Form
8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
¨
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
¨
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
¨
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
¨
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
ITEM 8.01 OTHER EVENTS.
On February 8, 2016, Phibro Animal Health Corporation
issued a press release announcing the declaration of a quarterly cash dividend of $0.10 per share on its Class A common stock and
Class B common stock, payable on March 23, 2016, to stockholders of record at the close of business on March 2, 2016. A copy of
the press release announcing the dividend is filed as Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein
by reference.
ITEM 9.01 FINANCIAL STATEMENTS AND EXHIBITS.
(d) Exhibits
Exhibit
Number |
|
Description |
| 99.1 |
|
Press Release, dated February 8, 2016. |
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
thereunto duly authorized.
| |
PHIBRO ANIMAL HEALTH CORPORATION
Registrant |
| |
|
| Date: February 8, 2016 |
|
| |
|
| |
By: |
/s/ Thomas G. Dagger |
| |
Name: |
Thomas G. Dagger |
| |
Title: |
Senior Vice President, General Counsel |
| |
|
and Corporate Secretary |
